Home › Medical Devices
Medical Devices Market Research Reports & Consulting
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Occlusion Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User - Global Forecast to 2023The global occlusion devices market is projected to reach USD 3.55 Billion by 2023 from USD 2.74 Billion in 2018, at a CAGR of 5.3%. The growth witnessed by occlusion devices is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for occlusion devices across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Medtronic (Ireland), Terumo (Japan), Stryker Corporation (US), and Penumbra (US). Other prominent players present in this market are Abbott (US), Cardinal Health (US), B. Braun (Germany), Asahi Intecc (Japan), C.R. Bard (US), Cook Group (US), Angiodynamics (US), and Acrostak (US). |
April 2018 | $ 4950 |
|
Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022The global infectious disease diagnostics market is projected to reach $19.35 Billion in 2022 from $14.73 Billion in 2017, at CAGR of 5.6%. Infectious disease diagnostics are various techniques used by healthcare professionals to detect and diagnose diseases causing pathogens in human samples such as serum, blood, urine, throat swab, and stool. Growth in infectious disease diagnostic instruments market is largely be driven by the increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics. The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMérieux (France), Bio-Rad (US), and Roche (Switzerland). |
April 2018 | $ 4950 |
|
Surgical Drapes and Gowns Market by Type (Drapes (Cardiovascular, General Surgery, C- Section, Lithotomy, Laparoscopy, Ophthalmic), Gown (Standard, Reinforced, High-Performance)), Utility (Reusable, Disposable), End User (Hospital) - Global Forecast to 2023The global surgical drapes and gowns market is expected to reach USD 3.14 Billion by 2023 from USD 2.47 Billion in 2018, at a CAGR of 4.9%. Major industry players launched innovative products to maintain and improve their position in the surgical drapes and gowns market. Cardinal Health (US), 3M (US), Mölnlycke Health Care (Sweden), Halyard Health (US), Thermo Fisher Scientific Inc. (US), Steris plc (US), and Paul Hartmann AG (Germany) have been identified as the key players in this market. |
April 2018 | $ 4950 |
|
Orthodontic Supplies Market by Product (Removable, Fixed Braces (Brackets (Self Ligating, Lingual), Archwire (Ni-Ti, Stainless Steel), Anchorage (Buccal Tube, Band), Ligature (Elastomeric, Wire)), Retainers), Patient, and Region - Global Forecast to 2023The global orthodontic supplies market is expected to reach USD 6.63 Billion by 2023 from USD 4.32 Billion in 2018, growing at a CAGR of 8.9%. The growing number of patients with malocclusions, jaw diseases, tooth decay/tooth loss, and jaw pain; increasing disposable incomes and expanding middle-class population in developing countries; increasing awareness about advanced orthodontic treatments; and ongoing research and technological advancements in orthodontic products are the key factors driving the growth of this market. The major players operating in the orthodontic supplies market include Align Technology, Inc. (US), 3M Company (US), Danaher Corporation (US), Henry Schien, Inc. (US), DENTSPLY SIRONA, Inc. (US), American Orthodontics (US), Rocky Mountain Orthodontics (US), G&H Orthodontics (US), DENTAURUM GmbH & Co. (Germany), TP Orthodontics, Inc. (US), ClearCorrect (a subsidiary of Straumann Holding AG, Switzerland), Ultradent Products, Inc. (US), Great Lakes Orthodontics, Ltd. (US), DB Orthodontics (UK), and Dental Morelli Ltda. (Brazil), among others. |
April 2018 | $ 4950 |
|
Neuroendoscopy Market by Product (Rigid (Videoscope, Fiberscope), Flexible endoscope), Usability (Reuse and Disposable), Application (Transnasal, Intraventricular, and Transcranial), Region (North America, Europe, Asia) - Global Forecast to 2022The global neuroendoscopy devices market is expected to reach USD 218.9 Million by 2022 from USD 170.5 Million in 2017, at a CAGR of 5.1% during the forecast period. Factors such favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery are driving the growth of this market. The report segments the global neuroendoscopy devices market into product, application, usability, and region. The neuroendoscopy devices market includes various small and large players. Key players in this market are KARL STORZ (Germany), B.Braun Aesculap (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hawk (China), Machida (Japan), Tonglu Wanhe Medical (China), Schindler (Germany), Clarus (US), LocaMed (UK), and Visionsense (US). |
April 2018 | $ 4950 |
|
Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023The sepsis diagnostics market is expected to reach USD 564.1 Million by 2021 from USD 370.0 Million in 2016, at a CAGR of 8.8% during the forecast period. Rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and increase in the number of product approvals are supporting the growth of this market. However, lack of standard protocols and awareness as well as shortage of skilled staff are the major challenges in this market. The major players of the sepsis diagnostics market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany). |
April 2018 | $ 4950 |
|
Dental Implants and Prosthesis Market by Type (Dental Implants, Bridge, Crown, Abutment, Dentures, Veneers, Inlay & Onlays), Material (Titanium, Zirconium, Metal, Ceramic, Porcelain Fused To Metal), Type of Facility - Global Forecast to 2023The global market is projected to reach USD 13.01 billion by 2023 from USD 9.50 billion in 2018, at a CAGR of 6.5%. The growth of this market is driven by the growth in the geriatric population and corresponding age-related dental diseases, rising prevalence of tooth decay and periodontal diseases in the overall population across the globe, increasing willingness to adopt dental cosmetic surgery, and the growing number of implant placing dentists. However, the high cost of premium dental implants and limited reimbursement, and high risk of tooth loss associated with dental bridges may expect to hinder the growth of this market during the forecast period. The dental implants and prosthesis market is fragmented market; and some of the major players competing in this market are Institut Straumann AG (Switzerland), DENTSPLY Sirona Inc. (US), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), AVINENT Implant System (Spain), Henry Schein, Inc. (US), OSSTEM Implant Co., Ltd. (South Korea), DIO Corporation (South Korea), Merz Dental GmbH (Germany), Bicon, LLC (US), Shofu Dental Corporation (Japan), Thommen Medical AG (Switzerland), and Southern Implant (South Africa). |
March 2018 | $ 4950 |
|
Ophthalmic Equipment Market by Product (Optical Coherence Tomography (OCT), Fundus Camera, Ultrasound, Ophthalmoscope, Phoropter, Slit Lamp, Perimeter, Keratometer, Tonometer, IOL, Femtosecond Laser, Surgical Microscope, Contact Lenses) - Global Forecasts to 2023The ophthalmic equipment market is estimated to reach $58.44 Billion by 2023 from $49.30 Billion in 2018, at a CAGR of 3.5%. Rapid growth in the geriatric population and associated increase in the prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and rising adoption of contact lenses and spectacles are the major factors driving the growth of Ophthalmology Devices Market. However, the high-cost ophthalmic devices and reimbursement cuts for ophthalmic surgical procedures may hinder the growth of this market. Furthermore, the lack of awareness and low accessibility to eye care products in low-income economies is a major challenge for the growth of the ophthalmic equipment market. The prominent players in the ophthalmic equipment market are Essilor (France), Alcon (Switzerland), Johnson & Johnson Vision Care (US), Bausch + Lomb (US), Haag-Streit (Switzerland), TOPCON (Japan), Carl Zeiss Meditec (Germany), NIDEK (Japan), STAAR Surgical (US), HOYA (Japan), and Ziemer Ophthalmic Systems (Switzerland) |
March 2018 | $ 7150 |
|
In Vitro Diagnostics Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023The global in vitro diagnostics market is projected to reach USD 87.93 Billion by 2023 from USD 68.12 Billion in 2018, at a CAGR of 5.2%. The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the key factors driving the growth of the market. The prominent players in the global in vitro diagnostics market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Agilent Technologies (US), and QIAGEN (Germany). |
March 2018 | $ 4950 |
|
Urgent Care Center Market by Service (Acute Illness Treatment, Trauma/Injury Treatment, Physical Examination, Immunization & Vaccination), Ownership (Corporate Owned, Physician Owned, Hospital Owned), and Region - Global Forecast to 2023The global urgent care center market is projected to reach USD 25.93 Billion by 2023 from USD 20.07 Billion in 2018, at a CAGR of 5.3% during the forecast period. The growth of this market is driven by factors such as growing investments in urgent care, increasing geriatric population, strategic developments between urgent care providers and hospitals, and affordable care and shorter waiting periods offered by urgent care centers. Concentra (US), MedExpress (US), American Family Care (US), NextCare Holdings (US), and FastMed Urgent Care (US) are the key players in the urgent care center market. Other players involved in this market are CityMD (US), CareNow Urgent Care (US), GoHealth Urgent Care (US), HCA Healthcare UK (UK), Columbia Asia Hospitals (India), International SOS (China), and St. Joseph's Health Care London (Canada). |
March 2018 | $ 4950 |
|
Medical Display Market by Technology (LED, OLED) Panel Size (≤22.9”, 27.0-41.9”, ≥42”) Resolution (≤2MP, 4.1-8MP, ≥8MP), Application (Radiology, Mammography, Digital Pathology, Multi-modality, Surgical), & Display color - Global Forecast to 2023The global medical display market is projected to reach USD 2.33 Billion by 2023 from USD 1.86 Billion in 2018, at a CAGR of 4.6%. Growing adoption of hybrid ORs, short replacement cycle of medical displays, increasing preference for minimally invasive treatments, and rising number of Diagnostic Imaging centers are the major factors driving the growth of the market. However, market saturation and the increased adoption of refurbished medical displays are expected to restrain the growth of this market to a certain extent. Prominent players in the healthcare medical display market include Barco (Belgium), EIZO (Japan), Sony (Japan), LG Display (South Korea), Novanta (US), FSN Medical (South Korea), Advantech (Taiwan), Quest International (US), STERIS (UK), Jusha Medical (China), Double Black Imaging (US), Dell (US), HP (US), Shenzhen Beacon Display (China), COJE Display (South Korea), and Axiomtek (Taiwan). |
March 2018 | $ 4950 |
|
Automated blood Tube Labeler & Specimen Transport Box Market – By End User (Hospitals, Diagnostic Center, Skilled Nursing Facility, Long Term Acute Care Facilities), Specimen Transport Box Type (Traditional Boxes, Smart Transportation Boxes) - Forecast to 2022The automated blood tube labeler market is expected to reach USD 142.0 Million by 2022 from USD 102.3 Million in 2017, at a CAGR of 6.8% during the forecast period. The scope of the report includes automated tube labeler used to label blood tubes. The specimen transportation box market is expected to reach USD 135.8 Million by 2022 from USD 94.7 Million in 2017, at a CAGR of 7.5% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The automated tube labeler market is dominated by players such as Techno Medica (Japan), Kobayashi Create (Japan), and Inpeco (Switzerland). The major players in specimen transport box market include Sonoco Product Company (US), Greiner Holding (Austria), and Alifax Holdings (Italy). |
March 2018 | $ 4950 |
|
Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) - Global Forecast 2022The transradial access devices market is projected to reach USD 2.18 Billion by 2022 from USD 1.52 Billion in 2017, at a CAGR of 7.5%. The prominent players include Becton, Dickinson and Company (US) and Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic (Ireland), Merit Medical System, Inc. (US), Boston Scientific (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), and OSCOR Inc. (US). |
March 2018 | $ 4950 |
|
Colposcopy Market by Instrument Type (Optical, Digital), Portability (Fixed, Portable, Handheld), Application (Cervical Cancer Diagnosis, Physical Examination), End User (Hospitals, Clinics, Diagnostic Centres), and Region - Global Forecast to 2023The global colposcopy market is expected to reach USD 740.1 Million by 2023 from USD 532.6 Million in 2018, at a CAGR of 6.8%. Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market. Key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany). |
March 2018 | $ 4950 |
|
Endoscopic Vessel Harvesting Market by Product (EVH systems, Endoscope, Accessories), Usability (Disposable, Reusable), Vessel (Saphenous Vein, Radial Artery), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast to 2022The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. The key players in the global endoscopic vessel harvesting market are Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (Italy). |
March 2018 | $ 4950 |
|
Cranial Fixation & Stabilization Systems Market by Product (Screw, Mesh, Skullclamp, Horseshoe Headrest, Accessories, Adaptor, Arms, Base units), Material (Nonresorbable, Resorbable), End User (Hospitals, ASC), and Region - Global Forecast to 2022The global cranial fixation and stabilization systems market is expected to reach USD 1.74 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 8.7%. The growth of this market is mainly driven by the increasing prevalence of neurological diseases and high incidence of road accidents and fall related injuries. The cranial fixation and stabilization systems market is highly competitive with the presence of several large as well as emerging players. Prominent players in the cranial fixation and stabilization systems market include B. Braun (Germany), Changzhou Huida (China), DePuy Synthes (US), Evonos (Germany), Integra (US), Jeil Medical (South Korea), KLS Martin (Germany), Medicon (Germany), Medtronic (Ireland), Micromar (Brazil), NEOS Surgery (Spain), OsteoMed (US), Pro Med Instruments (Germany), Stryker (US), and Zimmer Biomet (US). |
March 2018 | $ 4950 |
|
Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022The global injection pen market is projected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017 at a CAGR of 6.0% during the forecast period. The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support. The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), Sanofi (France), Ypsomed (Switzerland), Merck (Germany), AstraZeneca (UK), F. Hoffman-la Roche (Switzerland), Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland). |
February 2018 | $ 4950 |
|
Arthroscopy Instruments Market by Type (Implants, Arthroscope, Visualization System, Surgical Shaver, RF Ablation, Fluid Management), Application (Knee, Hip, Shoulder), End User (Hospitals, Ambulatory Surgery Centers & Clinics) - Global Forecast to 2022The global arthroscopy instruments market is projected to reach USD 5.61 Billion by 2022 from USD 4.17 Billion in 2017, at a CAGR of 6.1% during the forecast period. The high incidence of sport-related injuries; technological advancements in arthroscopy products; and efficient reimbursement systems in developed countries are some of the factors driving the growth of the market. The major players of the arthroscopy instruments market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Zimmer Biomet (US), CONMED (US), Medtronic (Ireland), Karl Storz (Germany), B. Braun (Germany), Olympus (Japan), Richard Wolf (Germany), MEDICON (Germany), Sklar (US), Millennium (US), and GPC Medical (India). |
February 2018 | $ 4950 |
|
RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) - Global Forecast to 2022The global RSV diagnostics market is expected to reach USD 929.2 Million by 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg). |
February 2018 | $ 4950 |
|
Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023The global embolic protection devices market is projected to reach USD 604.9 Million by 2023 from USD 405.5 Million in 2018, at a CAGR of 8.3%. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. On the other hand, product failures and recalls may hinder the overall market growth to a certain extent during the forecast period. The prominent players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel). |
February 2018 | $ 4950 |
|
Microplate Systems Market by Product (Microplate Reader (Multi-mode {Hybrid}, Single-mode), Dispenser, Software), Application (Research, Clinical Diagnostics) & End User (Biotechnology, Pharmaceutical, Hospital, Diagnostic Labs) - Forecast to 2022The global microplate systems market is expected to reach USD 996.9 Million by 2022 from USD 820.3 Million in 2017 at a CAGR of 4.0%. The microplate systems market is highly competitive with the presence of several small and big players. Prominent players in this market include BioTek (US), Danaher (US), PerkinElmer (US), Tecan (Switzerland), Thermo Fisher (US), BMG LABTECH (Germany), BERTHOLD (Germany), Agilent (US), Bio-Rad (US), Promega (US), Biochrom (UK), Corning (US), Lonza (Switzerland), Rayto (China), and Mindray (China). |
February 2018 | $ 4950 |
|
Guidewires Market by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic (Hydrophilic, Hydrophobic)), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US). |
February 2018 | $ 4950 |
|
Intraocular Lens Market by Type (Traditional/Monofocal (Spheric, Aspheric), Premium (Multifocal, Accommodating, and Extended Depth of Focus), and Phakic), Material (PMMA, Foldable), End User (Hospital, Clinic), and Region - Global Forecast to 2022The global Intraocular Lens Market is projected to reach USD 4.56 Billion by 2022 from USD 3.50 Billion in 2017, at a CAGR of 5.4%. The growth of this market is majorly driven by the growth in the geriatric population and corresponding age-related eye disorders, rising prevalence of eye diseases & diabetes in the overall population across the globe, and increasing government initiatives to control and treat blindness caused by cataract. The key players in the global intraocular lenses market are Alcon, Inc. (US) (Novartis AG (Switzerland)), Bausch + Lomb (US) (Valeant Pharmaceuticals International (Canada)), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec (Germany), HOYA Corporation (Japan), STAAR Surgical Company (US), Rayner Intraocular Lenses Limited (UK), PhysIOL (Belgium), Ophtec BV (Netherlands), Swiss Advanced Vision (SAV IOL) (Switzerland), Oculentis GmbH (Germany), NIDEK CO., LTD. (Japan), Aurolab (India), Omni Lens Pvt Ltd. (India), Care Group (India), Hanita Lenses R.C.A Ltd. (Israel), and Fred Hollows Intraocular Laboratory (Eritrea). |
January 2018 | $ 4950 |
|
Medical Ceramics Market by Type of Material (Bioinert (Zirconia, Alumina), Bioactive (Hydroxyapatite, Glass Ceramics), Bioresorbable, Piezoceramics), Application (Dental, Orthopedic, Cardiovascular, Plastic Surgery), and Region - Global Forecast to 2022The global medical ceramics market is projected to reach USD 18.45 Billion by 2022 from USD 13.38 Billion in 2017, at a CAGR of 6.6%. The growth of this market is majorly driven by factors such as increasing research activities for the development of novel medical ceramics, growing demand for medical ceramics in plastic surgeries and wound healing applications, rising number of hip and knee replacement procedures, and increasing demand for implantable devices. Some of the key players in the medical ceramics market are CoorsTek (US), CeramTec (Germany), Kyocera (Japan), Morgan Advance Material (UK), NGK Spark Plug (Japan), DePuy Synthes (US), Zimmer Biomet (US), Rauschert (Germany), Straumann (Switzerland), H.C. Stark (Germany), 3M (US), and DSM (Netherlands). |
January 2018 | $ 4950 |
|
Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022The global autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%. The growing incidence of autoimmune diseases along population, technological advancements in analyzing devices, increasing access to medical insurance in the US, and increasing healthcare expenditure are key factors driving the growth of this market. Key players in the autoimmune disease diagnosis market include Thermo Fisher Scientific.(US), Danaher (US), HYCOR Biomedical (US), Siemens (Germany), Bio-Rad Laboratories. (US), and Abbott (US). |
January 2018 | $ 4950 |
|
Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023The global esoteric testing market is projected to reach USD 35.24 Billion by 2023 from USD 20.38 Billion in 2018, at a CAGR of 11.6%. The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, and advancements in clinical diagnostic techniques are the key factors driving the growth of the market. The prominent players in the global esoteric testing market include LabCorp (US), OPKO Health (US), ARUP Laboratories (US), Miraca Holdings (Japan), Myriad Genetics (US), Genomic Health (US), Quest Diagnostics (US), American Medical Laboratories (US), Foundation Medicine (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (Australia), Fulgent Genetics. (US), Invitae (US), Spectra Laboratories (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Enzo Biochem (US), Clinical Reference Laboratory (US), Sequenom (US), and American Pathology Partners (US). |
January 2018 | $ 4950 |
|
Bone Cement & Glue Market by Type (PMMA, Calcium Phosphate, Natural, Synthetic), Application (Arthroplasty (Total Knee, Hip, Shoulder), Kyphoplasty, Vertebroplasty), End User (Hospitals, Clinics, Ambulatory Surgery Centers) - Global Forecast to 2022The global bone cement and glue market is expected to reach USD 1,322.6 Million by 2022 from USD 993.0 Million in 2017, at a CAGR of 5.9%. The market growth is primarily driven by the growing incidence of sports injuries and increasing developments in Regenerative Medicine field. Key players in the bone cement and glue market include Stryker (US), Zimmer Biomet (US), DePuy Synthes (US), Smith & Nephew (UK), Arthrex (US), DJO Global (US), Exactech (US), TEKNIMED (France), Heraeus Medical (Germany), CryoLife (US), Cardinal Health (US), and Trimph (Australia). |
January 2018 | $ 4950 |
|
Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022The global vascular grafts market is expected to reach USD 3.80 Billion by 2022 from USD 2.67 Billion in 2017, at a CAGR of 7.3%. Growth in the vascular grafts market is mainly driven by the constant growth in the geriatric population and the corresponding prevalence of aneurysms, increasing incidence of end-stage renal disease, and the growing preference for minimally invasive surgeries. Key players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US). |
January 2018 | $ 4950 |
|
Antimicrobial Susceptibility Testing Market by Product (Automated System, Disks, MIC Strips, Media), Method (Dilution, Diffusion), Type (Antibacterial, Antifungal), Application (Clinical, Drug Discovery), End User (Labs, Hospitals) - Global Forecast to 2022The global antimicrobial susceptibility testing market is expected to reach USD 3.47 Billion by 2022 from USD 2.71 Billion in 2017, at a CAGR of 5.1%. Factors such as increasing prevalence of infectious diseases across the globe, emergence of antimicrobial resistance caused due to drug overuse, increasing initiatives by government organizations towards improving the detection and control antimicrobial resistant species, and improving growth opportunities in emerging markets are boosting the demand for antimicrobial susceptibility testing products. As of 2016, some of the major players operating in this market include bioM¨¦rieux (France), BD (US), Danaher (US), Thermo Fisher (US), and Bio-Rad (US). |
January 2018 | $ 4950 |
|
Wearable Medical Devices Market by Device (Diagnostic (Heart, Pulse, BP, Sleep), Therapeutic (Pain, Insulin, Rehabilitation)), Application (Sport, Fitness, RPM), Type (Smartwatch, Patch), Distribution Channel (Pharmacy, Online) - Global Forecast to 2022The wearable medical devices market is expected to reach USD 14.41 Billion by 2022 from USD 6.22 Billion in 2017, at a CAGR of 18.3% during the forecast period. Factors such as technological advances in medical devices, increasing penetration of smartphones and growing number of smartphone-based healthcare apps compatible with wearable devices, growing preference for Wireless Connectivity among healthcare providers, and increasing awareness about physical fitness are driving the growth of this market. The wearable medical devices market is highly competitive with several big and small players. Prominent players in this market include Fitbit (US), Philips (Netherlands), LifeWatch (Switzerland), Garmin (Switzerland), and Omron (Japan). The other players operating in this market include Drägerwerk (Germany), Nokia Technologies (US), Jawbone (US), Polar (Finland), Wor(l)d Global Network (US), Activeinsights (UK), VitalConnect (US), Xiaomi (China), Misfit (US), and Monica Healthcare (UK). |
January 2018 | $ 4950 |
|
Ventilator Market by Mobility (Intensive Care, Portable), Type (Adult, Infant), Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End User (Hospital, Home Care, Ambulatory Care Center, EMS) - Global Forecast to 2023The global ventilators market is projected to reach USD 1,261.9 Million by 2023 from USD 859.9 Million in 2018, at a CAGR of 8.0%. Rapid growth in the geriatric population, increasing incidence of preterm births, and rising number of ICU beds are the major factors driving the growth of the ventilators market. Moreover, the growing investments, favorable regulatory policies, and growth in the healthcare industry in emerging countries in the Asian region are expected to provide favorable growth opportunities for players operating in the ventilators market. The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland). |
January 2018 | $ 4950 |
|
Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) - Global Forecast to 2022Neuroprostheses uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment & brain, and convert the signals to restore functions such as loss of hearing and vision. They have applications in cognitive disorders, ophthalmic disorders, motor disorders, and auditory disorders. The global neuroprosthetics market is expected to reach USD 10.48 Billion by 2022 from USD 5.84 Billion in 2017, at a CAGR of 12.4%. Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are the major driving factors for this market. Some of the major players operating in the neuroprosthetics market are Boston Scientific (US), LivaNova (UK), Medtronic (US), Abbott (US), Cochlear (Australia), and Second sight (US). |
January 2018 | $ 4950 |
|
Nerve Monitoring System Market by Product (Nerve Monitor, Electrode, Probe, Accessories), Technology (EEG, EMG, EP, ECOG), Application (Neurosurgery, ENT Surgery, Spine Surgery, Cardiovascular Surgery), End User (Hospital, ASC) - Global Forecasts to 2022The global nerve monitoring system market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period. Increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are factors expected to drive the demand for nerve monitoring products during the study period. The major players of the nerve monitoring system market are Medtronic (Ireland), NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), and Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia). |
January 2018 | $ 4950 |
|
Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The drug screening market is highly competitive with the presence of several small and big players. Some of the players offering products for drug screening market include Alere (US), Thermo Fisher (US), Siemens Healthineers (US), Alfa Scientific Designs (US), Roche (Switzerland), MPD, Inc. (US), Shimadzu (Japan), OraSure (US), Lifeloc (US), and Drägerwerk (Germany). On the other hand, LabCorp (US), Quest Diagnostics (US), Psychemedics (US), Omega Laboratories (US), CRL (US), SureHire (Canada), and CannAmm (Canada). |
January 2018 | $ 4950 |
|
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) - Global Forecasts to 2022The global market for clinical laboratory services is projected to reach $146.41 billion by 2022 from $113.44 billion in 2017, at a CAGR of 5.2%. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others |
December 2017 | $ 4950 |
|
Amniocentesis Needle Market by Type (Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022The global amniocentesis Needles market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. Major industry players acquired companies and business units from other companies to maintain and improve their position in the amniocentesis Needles market. Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), and Cook Medical (US) have been identified as the key players in this market. |
December 2017 | $ 4950 |
|
Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User -Global Forecast to 2022The global kidney/renal function test market was valued at USD 558.3 Million in 2016 and expected to reach USD 790.1 Million by 2022, growing at a CAGR of 6.1% during the forecast period. Growth in the kidney function test market can primarily be attributed to factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, rapid growth in the geriatric population, and the rise in alcohol consumption are driving the growth of the market. The prominent players in the global kidney function/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK). |
December 2017 | $ 4950 |
|
Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022The global blood glucose monitoring system market was valued at USD 8.10 Billion in 2016 and is projected to reach USD 10.58 Billion by 2022, at a CAGR of 4.8% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. Rising prevalence of diabetic population, and increasing innovative product launches are factors driving the growth in the blood glucose monitoring system market. The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US). |
December 2017 | $ 4950 |
|
Optometry/Eye Exam Equipment Market by Type (OCT, Fundus Cameras, Perimeters, Ophthalmoscope, Ultrasound, Autorefractor, Slit Lamp, Corneal Topography, Lensmeter, Chart Projectors, Wavefront Analyzer), End User (Hospital, Clinic) - Global Forecast to 2022The global eye exam equipment market is projected to reach USD 3.05 Billion by 2022 from USD 2.29 Billion in 2017, at a CAGR of 6.0% during the forecast period. Growth in this market can primarily be attributed to the rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and increasing healthcare expenditure and rising disposable incomes. The prominent players in the global eye exam equipment market are Carl Ziess (Germany), Haag-Streit (Switzerland), Topcon (Japan), NIDEK (Japan), Heidelberg Engineering (Germany), Escalon (US), Novartis (Switzerland), Valent (Canada), Canon (Japan), Essilor (France), Heine Optotechnik (Germany), and Luneau Technology (France). |
December 2017 | $ 4950 |
|
EMS Products Market by Type (Laryngoscope, ET Tube, ECG, Pulse Oximeter, EEG, ICP, TCD, Temperature and Pre-Natal Monitors, Disinfectant, Dressing, Suture, Staple, Wheelchair, Beds), Application (Cardiac, Trauma), End User - Global Forecast to 2022The global emergency medical service (EMS) products market is expected to reach USD 25.56 Billion by 2022 from USD 19.01 Billion in 2017, at a CAGR of 6.1%. The market growth is primarily driven by the high demand for emergency care; increasing incidence of trauma injuries; and growing investments by government bodies on healthcare infrastructure development. Key players in the EMS products market include Stryker (US), Medtronic (Ireland), Asahi Kasei (Japan), Cardinal Health (US), Philips (Netherlands), GE Healthcare (US), Smith & Nephew (UK), 3M (US), Smiths Medical (UK), Becton, Dickinson (US), Johnson & Johnson (US), B. Braun (US), and C. R. Bard (US). |
December 2017 | $ 4950 |
|
Stoma/Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), and Accessories (Powder, Paste)), End User (Home, Hospital) - Global Forecast to 2022The global ostomy care market is projected to reach USD 2.99 Billion by 2022 from USD 2.40 Billion in 2017, at a CAGR of 4.5% during the forecast period. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of the ostomy market. The major players in the ostomy care market are ConvaTec (UK), Coloplast (Denmark), Hollister Incorporated (US), B. Braun (Germany), Alcare (Japan), Nu-Hope (US), Marlen (US), Welland Medical (UK), BAO-Health (China), Flexicare Medical (UK), Cymed (US), Schena Ostomy (US), Perma-Type (US), 3M (US), and Smith & Nephew (UK). |
December 2017 | $ 6780 |
|
Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022A gastrointestinal stent is a cylindrical medical device primarily used as a safe and effective alternative to surgery or repetitive endoscopic procedures to widen a narrow or stenosed lumen in order maintain the patency of the lumen. The gastrointestinal stents market is expected to reach USD 452.6 Million by 2022 from USD 337.5 Million in 2016, at a CAGR of 5.1% during the forecast period. The increasing preference for minimally invasive surgeries and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the gastrointestinal stents market. The prominent players in the global gastrointestinal stents market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), and M.I. Tech (South Korea). |
December 2017 | $ 4950 |
|
Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) - Global Forecast to 2022The global interventional cardiology devices market is expected to reach USD 20.85 Billion by 2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%. Market growth is primarily driven by the growing incidence of CVD and technological advancements in interventional cardiology devices. Key players in the interventional cardiology devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany). |
December 2017 | $ 4950 |
|
Ophthalmic Surgical Instruments Market by Product (Cataracts (IOL, OVD), Refractive (Femtosecond, Excimer Laser) Glaucoma, Vitreoretinal (Vitrectomy Machine & Packs) Surgical Microscope] End User (Hospital, Specialty Clinic) - Global Forecast to 2022The global ophthalmic surgical instruments market is expected to reach USD 11.18 Billion by 2022 from USD 7.87 Billion in 2016, at a CAGR of 6.0%. Growth in the global ophthalmic surgical instruments market is mainly driven by factors such as the increasing number of ophthalmic surgeries owing to the growth in geriatric population & related eye diseases, technological advancement in ophthalmic surgical devices, and government initiatives to increase the awareness about visual blindness across the globe. The prominent players in the ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland). |
November 2017 | $ 4950 |
|
Blood Warmer Devices/Sample Warmer Market by Sample (Blood, Embryo, Ovum, Semen), End User (Hospital, Blood Bank, Transfusion Center, Tissue Bank), Region (North America, Europe, Asia Pacific) - Global Forecast to 2022The blood warmer devices market is expected to reach USD 225.6 Million by 2022 from USD 138.7 Million in 2016 at a CAGR of 8.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Key players in the Tissue Diagnostics market include 3M (US), BD (US), The 37Company (Netherlands), Geratherm Medical (Germany), Stryker (US), Sarstedt (Germany), Barkey (Germany), Stihler Electronic (Germany), Belmont instrument (US), Biegler (Austria), and EMIT (US). |
November 2017 | $ 4950 |
|
Thawing System Market by Type (Manual, Automated), Sample (Blood, Plasma, RBC, Platelets, Whole Blood, Embryo, Semen), End User (Blood Bank, Transfusion Center, Hospital, Tissue Bank, Biotechnology & Pharmaceutical) - Global Forecast to 2022The thawing system market is expected to reach USD 252.7 Million by 2022 from USD 139.6 Million in 2017, at a CAGR of 12.6%. Factors driving the growth of this market include technological advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing use of thawed cells in the treatment of cancers and diabetes. Key players in the thawing system market include Helmer Scientific (US), Boekel Scientific (US), Sarstedt (Germany), Barkey (Germany), BioCision (US), Cardinal Health (US), Sartorius (Germany), GE Healthcare (US), Thermo Fisher Scientific (US), and CytoTherm (US). |
November 2017 | $ 4950 |
|
Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2022The global urology devices market is expected to reach USD 44.37 Billion by 2022 from USD 31.44 Billion in 2017, at a CAGR of 7.1%. The growing incidence of urological cancer along with a rapidly aging population, technological advancements in urology devices, and increasing healthcare expenditure are key factors driving the growth of this market. Key players in the urology devices market include Fresenius Medical Care (Germany), Baxter (US), Boston Scientific (US), Olympus (Japan), Richard Wolf (US), KARL STORZ (Germany), Cook Medical (US), Medtronic (US), C. R. Bard (US), Dornier MedTech (Germany), Prometheus Group (US), Medi-Globe (US), Intuitive Surgical (US), Merit Medical Systems (US), Siemens Healthcare (Germany), Stryker (US), ROCAMED (France), Medica (Italy), NOVAmedtek (Turkey), SRS Medical Systems (US), ProSurg (US), Albyn Medical (UK), EMD Medical Technologies (Canada), and Biolitec (Germany). |
November 2017 | $ 4950 |
|
Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User (Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022Blood collection is the process of acquiring blood samples from the donor for performing laboratory diagnostic tests and treating patients. This is an integral part of the blood management procedure in hospitals and blood banks centers. The global blood collection market is expected to reach USD 10.59 Billion by 2022 from USD 8.10 Billion in 2017, at a CAGR of 5.5% during forecast period. The increasing prevalence of various diseases, rising number of surgeries, and growing number of accidental and trauma cases are fueling the demand for blood collection products. The key players in the global blood collection market are BD (US), Medtronic (US), and Terumo (Japan). Some of the other players operating in this market are Haemonetics (US), Fresenius (Germany) Nipro Medical (US), Kawasumi Laboratories (Japan), F.L. Medical (Italy), Greiner Holding (Austria), and Grifols (Spain). |
November 2017 | $ 4950 |
|
Surgical Imaging Market by Technology (Image Intensifier C-arms, Flat Panel Detector C-arms (FPD C-arms)), Application (Orthopaedic & Trauma Surgeries, Neurosurgeries, Cardiovascular Surgeries), and Region - Global Forecasts to 2022The global surgical imaging market is projected to reach USD 1.63 Billion by 2022 from USD 1.25 Billion in 2017, at a CAGR of 5.5% during the forecast period. The growth of this market is majorly driven by factors such as technological advancements in C-arms, increasing demand for minimally invasive procedures, rising geriatric population, and growing chronic disease prevalence. GE Healthcare (US), Koninklijke Philips (Netherlands), Siemens (Germany), and Ziehm Imaging (Germany) are the key players in the surgical imaging market. Other players involved in this market are Hologic (US), Shimadzu Corporation (Japan), OrthoScan (US), Medtronic (US), Toshiba Medical Systems Corporation (Japan), GENORAY (South Korea), Eurocolumbus (Italy), and Allengers Medical Systems (India). |
November 2017 | $ 4950 |
|
Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, Nebulizer, Hearing Aids, Pedometer, Cane, Crutches, Wheelchair), Software, Services (Rehabilitation, Pregnancy, Palliative), & Telehealth - Global Forecast to 2022The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 239.30 Billion in 2017, at a CAGR of 8.8%. The growth of this market is mainly driven by the growing geriatric population; increasing incidence of chronic diseases; and rising demand for affordable healthcare delivery systems due to increasing healthcare cost, technological advancements, and government initiatives to promote home healthcare. The home healthcare market is highly competitive with the presence of several small and big players. Prominent players in the home healthcare market include Philips Healthcare (Netherlands), Kindred Healthcare (US), Linde Group (Germany), Almost Family Inc. (US), Abbott Laboratories (US), LHC Group (US), A&D (Japan), Amedisys (US), Fresenius (Germany), Omron (Japan), McKesson (US), BAYADA Home Health Care (US), Kinnser Software, Inc. (US), and Roche (Switzerland). |
November 2017 | $ 4950 |
|
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement
Connect With Us
Search reports
Medical Devices ›
Information and Communications Technology ›
Semiconductor and Electronics ›
Chemicals ›
Advanced Materials ›
Energy and Power ›
Food and Beverage ›
Biotechnology ›
Aerospace and Defence ›
Healthcare IT ›
Automotive and Transportation ›
Automation and Process Control ›
Agriculture Industry ›
Packaging ›
Pharmaceuticals ›
Building and Construction ›
Mining, Minerals and Metals ›
Analytical and Scientific Instrumentation ›
Engineering Equipment and Devices ›
'Connect With Us
